![]() |
Letter to Editor
1 Second Internal Medicine Department – Covid, General Hospital of Volos, Volos, Greece
2 Oncology Department, General Hospital of Volos, Volos, Greece
Address correspondence to:
Evangelos Potolidis
MD, ThB, MA, Consultant in Internal Medicine and Diabetology, General Hospital of Volos, Volos,
Greece
Message to Corresponding Author
Article ID: 101264Z01TM2021
No Abstract
Keywords: Black hairy tongue (BHT), COVID-19, Levofloxacin
Maria Tzikopoulou - Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published
Evangelos Potolidis - Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published
Charalampos Mandros - Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published
Eleni-Isidora Perdikouri - Substantial contributions to conception and design, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2021 Maria Tzikopoulou et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.